Security key
44486Q111
- Security type / class
- Equity / *W EXP 08/27/202
- Total 13F shares
- 528,391
- Total 13F value
- $1,544,000
- Share change
- +528,391
- SEC-reported price per share
- $2.90
- Number of holders
- 12
- Value change
- +$1,544,000
- Number of buys
- 12
Report period
Q3 2021
Institutions
12
Top holders
10
HUMAW full security history
Ownership snapshot
Full 13F holder table
Humacyte, Inc. SEC filings
Humacyte, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of HUMAW - Humacyte, Inc. - *W EXP 08/27/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRESENIUS MEDICAL CARE HO...
Disclosed value leader
FRESENIUS MEDICAL CARE HO...
Comparable rows
0/15
Latest evidence
26 Aug 2021
3/4/5
13F
Highest disclosed value: $21,792,154
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ has the largest disclosed position value at $21.79M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.
Disclosed position value
Top 5
FRESENIUS MEDICAL CARE HOLDINGS I...
$21.79M
Maven Securities LTD
$5.1M
TUDOR INVESTMENT CORP ET AL
$4.1M
OCONNOR, A Distinct Business Unit...
$3.06M
Altium Capital Management LLC
$2.8M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ |
3/4/5
Former 10% Shareholder
|
—
denominator unverified
|
$21,792,154
18,312,735 shares
|
— | 26 Aug 2021 |
| Maven Securities LTD |
13F
Company
|
—
denominator unverified
|
$5,095,000
500,000 shares
|
— | 30 Jun 2021 |
| TUDOR INVESTMENT CORP ET AL |
13F
Company
|
—
denominator unverified
|
$4,104,000
402,795 shares
|
— | 30 Jun 2021 |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
Company
|
—
denominator unverified
|
$3,057,000
300,000 shares
|
— | 30 Jun 2021 |
| Altium Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$2,802,000
275,000 shares
|
— | 30 Jun 2021 |
| COWEN AND COMPANY, LLC |
13F
Company
|
—
denominator unverified
|
$2,453,000
240,690 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
528,391
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
0
Q3 2021 holders
12
Holder diff
12
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|